Trials / Completed
CompletedNCT01188356
EMERALD - AssEssment of CoMorbidities & Atrial ArRhythmiA Burden in DuaL-Chamber PaceD Patients
AssEssment of CoMorbidities & Atrial ArRhythmiA Burden in DuaL-Chamber PaceD Patients
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 4,350 (actual)
- Sponsor
- MicroPort CRM · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to evaluate the incidence and evolution over-time of co-morbidities in a general dual-chamber pacemaker population (n=2188 patients) through a 2 years follow-up.
Detailed description
The study will focus on the number of patients moving to persistent Atrial Fibrillation as a function of cumulative %Vp (\< or \>40%), in a general dual-chamber pacemaker population through a 2 year follow-up (n=2188). The same endpoint will be analyzed in sub populations (Sinus Node Disease and AVB) at 4 years follow up (n=4290).
Conditions
Timeline
- Start date
- 2010-03-01
- Primary completion
- 2015-04-01
- Completion
- 2017-08-31
- First posted
- 2010-08-25
- Last updated
- 2019-03-25
Locations
190 sites across 12 countries: United States, Australia, Belgium, Canada, Denmark, France, Germany, Italy, Japan, Netherlands, Spain, Switzerland
Source: ClinicalTrials.gov record NCT01188356. Inclusion in this directory is not an endorsement.